ZNF419 and prostate adenocarcinoma: The negative correlation between ZNF419 expression and the infiltration score of immune cells in the TME of PRAD may partly explain this phenomenon because patients with high ZNF419 expression levels had less immune cell infiltration (thus worse antitumor immunity) and worse prognosis.